[(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate
C35H33ClF7N9O3 — CID 138552426
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate
[(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate (PubChem CID 138552426) has the molecular formula C35H33ClF7N9O3 and a molecular weight of 796.15 g/mol. Its IUPAC name is [(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate.
Molecular Properties
| Compound Name | [(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate |
|---|---|
| PubChem CID | 138552426 |
| Molecular Formula | C35H33ClF7N9O3 |
| Molecular Weight | 796.15 g/mol |
| Exact Mass | 795.23 |
| IUPAC Name | [(2S)-2-[(4S)-2-amino-4-[4-[1-(difluoromethyl)pyrazol-4-yl]phenyl]-4-(3,3-dimethylbut-1-en-2-yl)-5-oxoimidazol-1-yl]-2-[4-chloro-3-[5-(difluoromethyl)-1,2,4-triazol-1-yl]phenyl]ethyl] N-[1-(trifluoromethyl)cyclopropyl]carbamate |
| SMILES | C=C(C(C)(C)C)[C@]1(c2ccc(-c3cnn(C(F)F)c3)cc2)N=C(N)N([C@H](COC(=O)NC2(C(F)(F)F)CC2)c2ccc(Cl)c(-n3ncnc3C(F)F)c2)C1=O |
| InChI | InChI=1S/C35H33ClF7N9O3/c1-18(32(2,3)4)34(22-8-5-19(6-9-22)21-14-46-50(15-21)29(39)40)28(53)51(30(44)48-34)25(16-55-31(54)49-33(11-12-33)35(41,42)43)20-7-10-23(36)24(13-20)52-27(26(37)38)45-17-47-52/h5-10,13-15,17,25-26,29H,1,11-12,16H2,2-4H3,(H2,44,48)(H,49,54)/t25-,34-/m1/s1 |
| InChIKey | KMICLDTUEOQUAO-QCBOHVIISA-N |
| XLogP | 7.63 |
| TPSA | 145.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 796.15 |
| LogP ≤ 5 | 7.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138552426 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.